Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew P Feinberg

Showing results (11-20 of 166) with videos related to

Pageof 17
Sort By:
The New England Journal of Medicine|April 5, 2018
The Key Role of Epigenetics in Human Disease Prevention and MitigationAndrew P Feinberg
Nature Reviews. Cancer|January 21, 2004
The history of cancer epigeneticsAndrew P Feinberg, Benjamin Tycko
Cancer Research|December 17, 2005
Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor riskAtsushi Kaneda, Andrew P Feinberg
Nature Reviews. Cancer|June 14, 2013
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the hostWinston Timp, Andrew P Feinberg
Science (New York, N.Y.)|February 9, 2023
Epigenetics as a mediator of plasticity in cancerAndrew P Feinberg, Andre Levchenko
Cell|March 20, 2012
Regulated noise in the epigenetic landscape of development and diseaseElisabet Pujadas, Andrew P Feinberg
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2011
A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcriptPatrick Onyango, Andrew P Feinberg
American Journal of Human Genetics|March 3, 2004
Epigenetics and assisted reproductive technology: a call for investigationEmily L Niemitz, Andrew P Feinberg
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Evolution in health and medicine Sackler colloquium: Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and diseaseAndrew P Feinberg, Rafael A Irizarry
The New England Journal of Medicine|February 16, 2007
Genetics and epigenetics--nature's pen-and-pencil setRoger G Gosden, Andrew P Feinberg
Pageof 17

Showing results (11-20 of 166) with videos related to

Sort By:
Pageof 17
The New England Journal of Medicine|April 5, 2018
The Key Role of Epigenetics in Human Disease Prevention and MitigationAndrew P Feinberg
Nature Reviews. Cancer|January 21, 2004
The history of cancer epigeneticsAndrew P Feinberg, Benjamin Tycko
Cancer Research|December 17, 2005
Loss of imprinting of IGF2: a common epigenetic modifier of intestinal tumor riskAtsushi Kaneda, Andrew P Feinberg
Nature Reviews. Cancer|June 14, 2013
Cancer as a dysregulated epigenome allowing cellular growth advantage at the expense of the hostWinston Timp, Andrew P Feinberg
Science (New York, N.Y.)|February 9, 2023
Epigenetics as a mediator of plasticity in cancerAndrew P Feinberg, Andre Levchenko
Cell|March 20, 2012
Regulated noise in the epigenetic landscape of development and diseaseElisabet Pujadas, Andrew P Feinberg
Proceedings of the National Academy of Sciences of the United States of America|September 24, 2011
A nucleolar protein, H19 opposite tumor suppressor (HOTS), is a tumor growth inhibitor encoded by a human imprinted H19 antisense transcriptPatrick Onyango, Andrew P Feinberg
American Journal of Human Genetics|March 3, 2004
Epigenetics and assisted reproductive technology: a call for investigationEmily L Niemitz, Andrew P Feinberg
Proceedings of the National Academy of Sciences of the United States of America|January 19, 2010
Evolution in health and medicine Sackler colloquium: Stochastic epigenetic variation as a driving force of development, evolutionary adaptation, and diseaseAndrew P Feinberg, Rafael A Irizarry
The New England Journal of Medicine|February 16, 2007
Genetics and epigenetics--nature's pen-and-pencil setRoger G Gosden, Andrew P Feinberg
Pageof 17